PercipEnz, the OnCore PeopleHome

PercipEnz Ranked Among Inc. Magazine’s Fourth Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000

August 26th, 2010

Inc. 5000 LogoNEW YORK, August 24, 2010Inc. magazine today ranked PercipEnz Technologies  No.  2562 on its fourth annual Inc. 5000, an exclusive ranking of the nation’s fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent-minded entrepreneurs. Music website Pandora, convenience store chain 7-Eleven, Brooklyn Brewery, and Radio Flyer, maker of the iconic children’s red wagon, are among the prominent brands featured on this year’s list.

“The leaders of the companies on this year’s Inc. 5000 have figured out how to grow their businesses during the longest recession since the Great Depression,” said Inc. president Bob LaPointe. “The 2010 Inc. 5000 showcases a particularly hardy group of entrepreneurs.”

PercipEnz was the only honoree from Wisconsin in the Software category. Overall, PercipEnz ranked 164th out of a total of 272 companies in this category.  There were 61 companies on the Inc. 5000 list from Wisconsin. Among its neighbors, PercipEnz ranked 16th with a three-year growth rate of 92%.

PercipEnz Technologies, Inc. has had a banner year receiving three other awards in 2010 in recognition of the company’s success,  viability, workplace environment, and community involvement. These were the Wisconsin Company to Watch award, the Dane County Small Business Awards, and the BioForward  Emerging Company Showcase recognition.

The 2010 Inc. 5000, unveiled today on Inc.com, serves as a unique illustration of the profound changes taking place in the U.S. economy. The Government Services sector showed the biggest gain in terms of the number of companies on the list, up 33 percent from last year to 335 companies. Government Services was also the second-fastest-growing sector in terms of median revenue growth, posting a 202 percent gain over the 2006-2009 measuring period. More than half of these companies are based in Maryland, Virginia, and Washington, D.C. The fastest-growing sector by median revenue growth was Real Estate, now just a tiny group of 38 young, small companies, which showed 231 percent median growth over the period. (There were 121 Real Estate firms on the inaugural Inc. 5000 in 2007.) Business Products & Services is the top industry by number of companies on the list (640) and total revenue ($80.7 billion), while Health is the biggest by total employment (287,726  jobs).

Despite the fact that most of this year’s measuring period of 2006-2009 took place during the latest recession, aggregate revenue among the companies on the list actually increased to $321.6 billion, up more than 50 percent from last year. The effects of the recession are seen, however, in the median three-year growth rate, which dropped to 96 percent from last year’s 126 percent. This year’s Inc. 5000 employ a record 1.4 million people, up from one million on last year’s list. With unemployment remaining stubbornly high, policymakers and business leaders will do well to look to the Inc. 5000 companies for fresh ideas on achieving growth and creating jobs.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found on www.inc.com/5000.

Methodology

The 2010 Inc. 500|5000 is ranked according to percentage revenue growth when comparing 2006 to 2009. To qualify, companies must have been founded and generating revenue by June 30, 2006. Additionally, they had to be based in the United States, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2009. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2006 is $80,000; the minimum for 2009 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. The top 10 percent of companies on the list constitute the Inc. 500, now in its 29th year.

About Inc. Magazine

Founded in 1979 and acquired in 2005 by Mansueto Ventures LLC, Inc. (www.inc.com) is the only major business magazine dedicated exclusively to owners and managers of growing private companies that delivers real solutions for today’s innovative company builders. With a total paid circulation of 712,647, Inc. provides hands-on tools and market-tested strategies for managing people, finances, sales, marketing, and technology. Visit us online at www.inc.com.

About the Inc. 500|5000 Conference

Each year, Inc. and Inc.com celebrate the remarkable achievements of today’s entrepreneurial superstars—the privately held small businesses that drive our economy. The Inc. 500|5000 Conference & Awards Ceremony brings together members of the Inc. community, both a new class of Inc. 500|5000 honorees and the list’s alumni, for three days of powerful networking, inspired learning, and momentous celebration. Please join us September 30–October 2, 2010, at the Gaylord National Resort and Convention Center in National Harbor, Maryland, located minutes from downtown Washington, D.C. For more information about the 2010 Inc. 500|5000 Conference & Awards Ceremony and to register, visit www.inc500conference.com or call 866-901-3205.

CONTACT:

For more information about PercipEnz Technologies, Inc. contact Kerri Phillips at kphillips@percipenz.com or by phone at (608) 826-6000.

Dana-Farber/Harvard Cancer Center Selects the OnCore(r) Clinical Research Management System

May 19th, 2010

MADISON, Wis. (May 20, 2010) – An extensive search for an integrated clinical research management system came to an end in February when Dana-Farber/Harvard Cancer Center (DF/HCC) selected the OnCore(r) system.

“At some level, we’ve been looking for a product over a decade,” said Jeffrey W. Clark, MD, Medical Director of Clinical Trials Operations at DF/HCC, and one of the people who helped spearhead the search for a new system. Unfortunately, a system that was sophisticated enough to handle the complexity of Dana-Farber/Harvard Cancer Center’s seven-institution consortium did not exist until recently.

“In many ways, we had gone as far as we could in improving the operation. What was really missing were the integrated systems that would give us the automation, information, and management decision making tools to take our clinical trials program to the next level,” said Beverly Ginsburg-Cooper, MBA, Associate Director for Administration at DF/HCC and Senior VP for Research at Dana-Farber Cancer Institute, who coordinated the Cancer Center’s formal effort to evaluate systems this past year.

Currently, DF/HCC uses informatics to support its clinical research operation. However, these systems are not fully integrated and there are opportunities to eliminate the duplication of effort and enhance the flow of data.

“We’re honored to be working with Dana-Farber/Harvard Cancer Center,” said Srini Kalluri, President & CEO of PercipEnz Technologies, Inc., the creator of OnCore. “Over the past ten years, not only has OnCore evolved to address the complex needs of large clinical research enterprises like Dana-Farber/Harvard Cancer Center, but also, PercipEnz has achieved an organizational maturity in terms of processes and people to be able to undertake such large implementations. We are pleased to see the high caliber team DF/HCC has dedicated to their OnCore implementation, and we are quite confident that, working collaboratively with this outstanding group of people, we can ensure a highly successful implementation.”

DF/HCC is comprised of seven separate independent institutions that function as a cohesive consortium. The center has a unified clinical trials structure with a single IRB, a single Protocol Review and Monitoring System, a single Data Safety and Monitoring Process, a single set of operating policies and procedures, and a centralized clinical trials infrastructure to support these functions. Additionally, the center has coordinated budgeting and contracting processes. But, each institution coordinates its own data management activities independently.
Immediately, the goal is to start using OnCore for all of the centralized administrative functions at DF/HCC. Additionally, there are several existing systems in place at the center that are under consideration for direct integration with OnCore. DF/HCC will also be identifying any critical functionality they would like to see added to OnCore.

Working Together to Improve Cancer Research and Care

PercipEnz’s reputation for service and responsiveness played a role in DF/HCC’s final decision to select the OnCore product. “Beyond any existing differences in features and functionality among the various systems we evaluated, service and the OnCore user community were a compelling factor in our decision,” said Ginsburg-Cooper.

The implementation of OnCore was kicked-off earlier this month at DF/HCC, and the center has already started participating in user community events and activities through Onsemble, a community comprised of OnCore users and others concerned with improving clinical research operations.

“With one of the largest Bone Marrow Transplant programs in the country, it is a priority and responsibility of Dana-Farber/Harvard Cancer Center to work together with the other cancer centers to develop a product that will benefit us all,” said Ginsburg-Cooper.

“In the end, we are all here to help people with cancer, and 30 different research centers should not have to reinvent the wheel over and over again,” said Clark.

About the Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest NCI-Designated Comprehensive Cancer Center, bringing together the cancer research efforts of seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.

DF/HCC has joined these seven renowned Harvard-affiliated institutions into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal — to find new and innovative ways to combat cancer.

For more information about DF/HCC visit its website: http://www.dfhcc.harvard.edu.

University of Alabama at Birmingham (UAB) Comprehensive Cancer Center Selects OnCore(r) as its Clinical Research Informatics Platform

April 20th, 2010

MADISON, Wis. (April 21, 2010) – When the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center decided to enhance their clinical research infrastructure, comprehensive functionality and a reputation for customer service contributed to their decision to select the OnCore(r) clinical research management system from PercipEnz Technologies, Inc. in December. Read More…

OnCore(r) Version 10.0 Brings it all Together for the Clinical Research Enterprise

April 4th, 2010

MADISON, Wis. (April 5, 2010) — This year’s release of the OnCore Clinical and Translational Research Software, Version 10.0, represents thousands of hours of development effort and incorporates work done in eight collaborative projects with research organizations around the country. Read More…

PercipEnz Technologies Honored as One of the 2010 “Wisconsin Companies to Watch”

March 5th, 2010

2010 Wisconsin Company to Watch

MADISON, Wis. (March 5, 2010) — PercipEnz Technologies, Inc. has been recognized as one of the thirty 2010 “Wisconsin Companies to Watch,” an awards program presented by the Wisconsin Entrepreneurs’ Network (WEN) with support from the Wisconsin Department of Commerce and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with the Edward Lowe Foundation. Read More…

Rutgers-Cleveland Clinic Consortium of AFIRM Selects OnCore(r) to Support its Collaborative Clinical Research on Regenerative Therapies

November 4th, 2009

MADISON, Wis. (November 4, 2009) — When evaluating what was needed to support a widely distributed consortium comprised of 15 organizations across the country who are conducting cutting-edge collaborative clinical research, the Rutgers-Cleveland Clinic Consortium (RCCC) selected the OnCore Clinical Research Management system (OnCore-CRM) to administer their studies and coordinate the group’s efforts.

The Rutgers-Cleveland Clinic Consortium is part of the Armed Forces Institute of Regenerative Medicine (AFIRM), a multi-institutional, interdisciplinary network working to develop advanced treatment options for the nation’s severely wounded servicemen and women. Read More…

University of Florida Shands Cancer Center Achieves Goal and Goes Live with OnCore in Under Four Months

October 1st, 2009

MADISON, Wis. (October 1, 2009) — The University of Florida Shands Cancer Center (UFSCC) set an aggressive timeline for their implementation of a new clinical research management system and, in just over three months, they met it. Back in June, the cancer clinical trials office began migrating data from their legacy system and rolling-out the OnCore system for clinical research management (OnCore-CRM). On Wednesday, September 23rd, the new OnCore users celebrated the go live of the new system with cake.

ShandsGoLive Read More…

Improving Research Efficiencies through Collaboration was theme of Onsemble 2009 Fall Conference

September 18th, 2009

MADISON, Wis. (September 18, 2009) — There just never seems to be enough time at the semi-annual Onsemble conferences. With a whirlwind of activity, the eighth face-to-face gathering of the OnCore community was no exception for the 117 people who attended. Read More…

University of Florida Shands Cancer Center Selects OnCore® to Support it’s Collaborative Research Goals

July 13th, 2009

MADISON, Wis. (July 13, 2009) — An institutional goal to develop collaborative partnerships with other research organizations was a key factor in the recent decision by the University of Florida Shands Cancer Center (UFSCC) to select OnCore® products in support of their clinical and translational research informatics needs. With the signing of the contract, the UFSCC has become the 25th cancer center to adopt the OnCore platform.

“We began looking for a new clinical trials management system primarily because of our collaborative agreement with the Moffitt Cancer Center,” said Giselle Moore-Higgs, Assistant Director of Clinical Trials at UFSCC. “We wanted a system that would allow us to do collaborative clinical research and share data with other organizations and OnCore allows us to do that.” Read More…

Workshop will Focus on Increasing Patient Accrual and Measuring Operational Effectiveness

June 20th, 2009

A Breadth of Perspectives to be Represented in this Half-Day Workshop

MADISON, Wis. (June 20, 2009) — A power-packed roundtable discussion has been assembled to explore issues around patient accrual as part of a pre-conference workshop at the upcoming Onsemble 2009 Fall Conference. For the fifth consecutive conference, a workshop will be included that is specifically designed for clinical trials office leadership. As in the past, this workshop will also focus on developing measurements, or “metrics,” for the purposes of understanding and improving clinical research operations. Read More…

Archives